Plus: 🏦 Dividend at a Discount, A watchlist of 30 underpriced quality companies
Narratives you
should be watching |
| |
|
- Why Mastercard isn't the payments giant being disrupted by, but the dividend compounder most investors are overlooking
- Why Intuit's biggest selloff in years might actually be its most compelling buying opportunity.
- Why Mindwalk isn't the wet-lab business it left behind years ago, but an AI drug discovery platform hiding in plain sight.
|
|
|
Mastercard: The Best Dividend Stock You're Ignoring |
|
| |
Why this Narrative made this week’s picks |
Stablecoin fears and regulatory noise have compressed Mastercard's multiple to a five-year low, while earnings keep growing in the mid-teens. Author argues the selloff is a sentiment story, not a business story, and that fourteen straight years of dividend raises with a low payout ratio makes this the most overlooked income compounder. |
Author’s valuation assumes ~14% p.a. revenue growth for 5 years. |
|
|
|
Intuit: A Wonderful Business at a Not-So-Wonderful Price |
|
| |
Why this Narrative made this week’s picks |
Intuit is down over sixty percent from its peak and is being priced like a franchise in freefall. Author tracks the drawdown, stress-tests every bear case, and concludes the QuickBooks moat is intact, the government tax filing threat is gone, and a decade-long dividend grower is now trading below author's revised worst case. |
Author’s valuation assumes ~10% p.a. revenue growth for 10 years. |
|
| |
The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect |
|
| |
Why this Narrative made this week’s picks |
MindWalk is an under-the-radar biotech company that has quietly reinvented itself from a niche wet-lab business into a high-margin SaaS platform for AI-driven drug discovery. Author argues the market hasn't noticed the transformation yet, and that a technology already producing breakthroughs is underpriced. |
Author’s valuation assumes an estimated revenue of US$ 140m in 5 years |
|
| |
 | Watchlist pick: Dividend at a Discount - 30 value & dividend companies 30 quality businesses from the US, Europe, and Canada with yields above 1.5%, mispriced by the market, not by their fundamentals. | | | See the list | |
|
|
Trusted by 7M+ Investors | Download the app |
This email is from Simply Wall Street Pty Ltd
Level 5, 320 Pitt St Sydney 2000, NSW, Australia. |
Simply Wall St has no position in any of the companies mentioned. These narratives are general in nature and reflect the authors’ own opinions only. They do not represent the views of Simply Wall St and do not constitute a recommendation to buy or sell any stock. Any scenarios or fair value estimates discussed are exploratory only, are not indicative of the company’s future performance, and do not take into account your objectives or financial situation. The authors’ analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this email/website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us. |
|
|
|
|
|
|
|
